INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208 | -17.8% | 4,000 | 0.0% | 0.03% | -15.0% |
| Q2 2023 | $253 | +16.6% | 4,000 | 0.0% | 0.04% | +21.2% |
| Q1 2023 | $217 | +2.4% | 4,000 | 0.0% | 0.03% | +6.5% |
| Q4 2022 | $212 | -99.9% | 4,000 | -11.1% | 0.03% | +10.7% |
| Q3 2022 | $209,000 | -22.0% | 4,500 | -4.3% | 0.03% | -17.6% |
| Q2 2022 | $268,000 | -6.9% | 4,700 | 0.0% | 0.03% | +13.3% |
| Q1 2022 | $288,000 | +17.1% | 4,700 | 0.0% | 0.03% | +25.0% |
| Q4 2021 | $246,000 | -32.4% | 4,700 | -66.9% | 0.02% | -56.4% |
| Q3 2020 | $364,000 | -9.7% | 14,200 | -9.6% | 0.06% | -29.5% |
| Q2 2020 | $403,000 | +46.5% | 15,700 | -12.3% | 0.08% | +27.9% |
| Q1 2020 | $275,000 | -55.2% | 17,900 | 0.0% | 0.06% | -47.9% |
| Q4 2019 | $614,000 | +358.2% | 17,900 | 0.0% | 0.12% | +368.0% |
| Q3 2019 | $134,000 | -43.0% | 17,900 | -1.1% | 0.02% | -49.0% |
| Q2 2019 | $235,000 | +6.8% | 18,100 | 0.0% | 0.05% | +2.1% |
| Q1 2019 | $220,000 | +6.8% | 18,100 | 0.0% | 0.05% | -2.0% |
| Q4 2018 | $206,000 | -54.3% | 18,100 | -13.0% | 0.05% | -47.3% |
| Q3 2018 | $451,000 | +22.6% | 20,800 | 0.0% | 0.09% | +16.2% |
| Q2 2018 | $368,000 | -16.7% | 20,800 | -1.0% | 0.08% | +247.8% |
| Q1 2018 | $442,000 | +44.4% | 21,000 | -0.5% | 0.02% | +53.3% |
| Q4 2017 | $306,000 | -78.8% | 21,100 | -77.0% | 0.02% | -79.7% |
| Q3 2017 | $1,445,000 | +58.3% | 91,544 | +24.5% | 0.07% | +51.0% |
| Q2 2017 | $913,000 | -24.0% | 73,544 | -0.5% | 0.05% | -23.4% |
| Q1 2017 | $1,202,000 | +7.7% | 73,944 | 0.0% | 0.06% | +3.2% |
| Q4 2016 | $1,116,000 | +3.8% | 73,944 | +4.8% | 0.06% | +5.1% |
| Q3 2016 | $1,075,000 | -47.9% | 70,544 | +32.7% | 0.06% | -52.0% |
| Q2 2016 | $2,063,000 | +39.7% | 53,144 | 0.0% | 0.12% | +43.0% |
| Q1 2016 | $1,477,000 | -47.1% | 53,144 | +2.3% | 0.09% | -42.7% |
| Q4 2015 | $2,794,000 | +32.0% | 51,944 | -1.7% | 0.15% | +30.4% |
| Q3 2015 | $2,116,000 | – | 52,844 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |